Add DOACs to Your List of Options for Treating HIT

April 2019

You'll get questions about using direct oral anticoagulants (DOACs) for heparin-induced thrombocytopenia (HIT).

We usually treat HIT with IV argatroban...or sometimes IV bivalirudin or subcutaneous fondaparinux. Then we transition to warfarin once the platelet count recovers...usually 150,000/mm3 or higher.

Now there's growing interest in using a DOAC to treat HIT. But data are limited, especially when considering DOACs as initial HIT treatment.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote